These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 26281146)
1. Early Intervention in Living Kidney Transplantation Based on Dynamic Monitoring of Donor Specific Antibodies. Chen Y; Li LY; Lou XY; Wang H; Zhang L; Zhu YH Clin Transpl; 2014; ():205-8. PubMed ID: 26281146 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience. Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J Clin Transpl; 2014; ():223-30. PubMed ID: 26281149 [TBL] [Abstract][Full Text] [Related]
3. De novo donor specific antibodies and patient outcomes in renal transplantation. DeVos JM; Patel SJ; Burns KM; Dilioglou S; Gaber LW; Knight RJ; Gaber AO; Land GA Clin Transpl; 2011; ():351-8. PubMed ID: 22755430 [TBL] [Abstract][Full Text] [Related]
4. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts. Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of post kidney transplant de novo DSA in otherwise stable grafts. Cooper JE; Gralla J; Chan L; Wiseman AC Clin Transpl; 2011; ():359-64. PubMed ID: 22755431 [TBL] [Abstract][Full Text] [Related]
6. High-Dose Intravenous Immunoglobulin Therapy for Donor Specific Antibodies in Kidney Transplant Recipients with Acute and Chronic Graft Dysfunction: Updates on Previously Reported Cohorts. Alfonso J; Gralla J; Klem P; Chan L; Wiseman AC; Cooper JE Clin Transpl; 2014; ():161-70. PubMed ID: 26281141 [TBL] [Abstract][Full Text] [Related]
7. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients. Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R Clin Transpl; 2014; ():215-21. PubMed ID: 26281148 [TBL] [Abstract][Full Text] [Related]